Downregulation of B lymphocyte stimulator expression by curcumin in B lymphocyte via suppressing nuclear translocation of NF-κB

European Journal of Pharmacology

Volumn 650, Issue 1, 2011, Pages 451-457

  Huang, Gang ^a   Yang, Yanchun ^a   Xu, Zhizhen ^a   Zhou, Peng ^a   Gong, Wei ^a   Li, Yuan ^a   Fan, Jishan ^a   He, Fengtian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune disease; B lymphocyte stimulator; Curcumin; NF B

Indexed keywords

B CELL ACTIVATING FACTOR; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG MECHANISM; ENZYME REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; AUTOIMMUNE DISEASES; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL LINE; CELL NUCLEUS; CURCUMIN; DNA; DOWN-REGULATION; HUMANS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR RELA;

EID: 78649754561     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.065     Document Type: Article

References (40)

1. B.B. Aggarwal, and K.B. Harikumar Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Int. J. Biochem. Cell Biol. 41 2009 40 59
2. S. Aggarwal, H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation Mol. Pharmacol. 69 2006 195 206
3. B.B. Aggarwal, S. Banerjee, U. Bharadwaj, B. Sung, S. Shishodia, and G. Sethi Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines Biochem. Pharmacol. 73 2007 1024 1032
4. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Lett. 267 2008 133 164
5. A. Becker-Merok, C. Nikolaisen, and H.C. Nossent B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time Lupus 15 2006 570 576
6. A.C. Bharti, N. Donato, S. Singh, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis Blood 101 2003 1053 1062
7. P. Briassouli, F. Chan, K. Savage, J.S. Reis-Filho, and S. Linardopoulos Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalpha Cancer Res. 67 2007 1689 1695
8. J.J. Bright Curcumin and autoimmune disease Adv. Exp. Med. Biol. 595 2007 425 451
9. C. Daridon, V. Devauchelle, P. Hutin, R. Le Berre, C. Martins-Carvalho, B. Bendaoud, M. Dueymes, A. Saraux, P. Youinou, and J.O. Pers Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome Arthritis Rheum. 56 2007 1134 1144
10. T. Dorner, A. Radbruch, and G.R. Burmester B-cell-directed therapies for autoimmune disease Nat. Rev. Rheumatol. 5 2009 433 441
11. L. Fu, Y.C. Lin-Lee, L.V. Pham, A. Tamayo, L. Yoshimura, and R.J. Ford Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas Blood 107 2006 4540 4548
12. L. Fu, Y.C. Lin-Lee, L.V. Pham, A.T. Tamayo, L.C. Yoshimura, and R.J. Ford BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells Blood 113 2009 4627 4636
13. J.L. Funk, J.N. Oyarzo, J.B. Frye, G. Chen, R.C. Lantz, S.D. Jolad, A.M. Solyom, and B.N. Timmermann Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis J. Nat. Prod. 69 2006 351 355
14. S. Ghosh, and M.S. Hayden New regulators of NF-kappaB in inflammation Nat. Rev. Immunol. 8 2008 837 848
15. J. Groom, S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, P. Schneider, J. Tschopp, T.G. Cachero, M. Batten, J. Wheway, D. Mauri, D. Cavill, T.P. Gordon, C.R. Mackay, and F. Mackay Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome J. Clin. Invest. 109 2002 59 68
16. A.R. Hussain, M. Ahmed, N.A. Al-Jomah, A.S. Khan, P. Manogaran, M. Sultana, J. Abubaker, L.C. Platanias, K.S. Al-Kuraya, and S. Uddin Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines Mol. Cancer Ther. 7 2008 3318 3329
17. J.K. Jackson, T. Higo, W.L. Hunter, and H.M. Burt The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis Inflamm. Res. 55 2006 168 175
18. G.C. Jagetia, and B.B. Aggarwal "Spicing up" of the immune system by curcumin J. Clin. Immunol. 27 2007 19 35
19. G.Y. Kim, K.H. Kim, S.H. Lee, M.S. Yoon, H.J. Lee, D.O. Moon, C.M. Lee, S.C. Ahn, Y.C. Park, and Y.M. Park Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets J. Immunol. 174 2005 8116 8124
20. M. Krivosikova, T. Dallos, W. Maslinski, and M. Buc B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases Bratisl. Lek. Listy 110 2009 137 145
21. A. Kurylowicz, and J. Nauman The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment Acta Biochim. Pol. 55 2008 629 647
22. F. Lavie, C. Miceli-Richard, M. Ittah, J. Sellam, J.E. Gottenberg, and X. Mariette B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome Scand. J. Immunol. 67 2008 185 192
23. L. Le Pottier, B. Bendaoud, M. Dueymes, C. Daridon, P. Youinou, Y. Shoenfeld, and J.O. Pers BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer J. Clin. Immunol. 27 2007 257 265
24. S. Lev-Ari, D. Lichtenberg, and N. Arber Compositions for treatment of cancer and inflammation Recent Pat. Anticancer Drug Discov. 3 2008 55 62
25. A. Liacini, J. Sylvester, W.Q. Li, and M. Zafarullah Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes Matrix Biol. 21 2002 251 262
26. A. Liacini, J. Sylvester, W.Q. Li, W. Huang, F. Dehnade, M. Ahmad, and M. Zafarullah Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes Exp. Cell Res. 288 2003 208 217
27. A.K. Mankan, M.W. Lawless, S.G. Gray, D. Kelleher, and R. McManus NF-kappaB regulation: the nuclear response J. Cell. Mol. Med. 13 2009 631 643
28. E.Y. Moon, J.H. Lee, S.Y. Oh, S.K. Ryu, H.M. Kim, H.S. Kwak, and W.K. Yoon Reactive oxygen species augment B-cell-activating factor expression Free Radic. Biol. Med. 40 2006 2103 2111
29. K. Nakajima, K. Itoh, K. Nagatani, M. Okawa-Takatsuji, T. Fujii, H. Kuroki, Y. Katsuragawa, S. Aotsuka, and A. Mimori Expression of BAFF and BAFF-R in the synovial tissue of patients with rheumatoid arthritis Scand. J. Rheumatol. 36 2007 365 372
30. C. Park, D.O. Moon, I.W. Choi, B.T. Choi, T.J. Nam, C.H. Rhu, T.K. Kwon, W.H. Lee, G.Y. Kim, and Y.H. Choi Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis Int. J. Mol. Med. 20 2007 365 372
31. L.I. Reyes, F. Leon, P. Gonzalez, M.F. Rozas, C. Labarca, A. Segovia, O. Neira, and R. Naves Dexamethasone inhibits BAFF expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis Cytokine 42 2008 170 178
32. R. Sabahi, and J.H. Anolik B-cell-targeted therapy for systemic lupus erythematosus Drugs 66 2006 1933 1948
33. S. Shishodia, H.M. Amin, R. Lai, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma Biochem. Pharmacol. 70 2005 700 713
34. W. Stohl, D. Xu, K.S. Kim, M.N. Koss, T.N. Jorgensen, B. Deocharan, T.E. Metzger, S.A. Bixler, Y.S. Hong, C.M. Ambrose, F. Mackay, L. Morel, C. Putterman, B.L. Kotzin, and S.L. Kalled BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus Arthritis Rheum. 52 2005 2080 2091
35. Y.T. Tai, X.F. Li, I. Breitkreutz, W. Song, P. Neri, L. Catley, K. Podar, T. Hideshima, D. Chauhan, N. Raje, R. Schlossman, P. Richardson, N.C. Munshi, and K.C. Anderson Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment Cancer Res. 66 2006 6675 6682
36. R.K. Thomas, M.L. Sos, T. Zander, O. Mani, A. Popov, D. Berenbrinker, S. Smola-Hess, J.L. Schultze, and J. Wolf Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies Clin. Cancer Res. 11 2005 8186 8194
37. M. Tomita, H. Kawakami, J.N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, K. Ohshiro, and N. Mori Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells Int. J. Cancer 118 2006 765 772 (Pubitemid 43076029)
38. C. Varalakshmi, A.M. Ali, B.V. Pardhasaradhi, R.M. Srivastava, S. Singh, and A. Khar Immunomodulatory effects of curcumin: in-vivo Int. Immunopharmacol. 8 2008 688 700
39. L. Zhou, R. Zhong, W. Hao, H. Wang, X. Fan, L. Zhang, and Q. Mi Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells Exp. Mol. Pathol. 87 2009 54 58
40. X.J. Zhu, Y. Shi, J.Z. Sun, N.N. Shan, J. Peng, C.S. Guo, P. Qin, and M. Hou High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia J. Clin. Immunol. 29 2009 603 610